Comparison
22q Partial Monosomy C0265489 vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 22q Partial Monosomy and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
22q Partial Monosomy C0265489
A genetic disorder from missing material on chromosome 22, often called DiGeorge syndrome. It can affect the heart, immune system, and development. Requires lifelong specialized medical care.
13q12 3 Microdeletion Syndrome C4750951
A rare genetic condition where a small piece of chromosome 13 is missing. It can cause various developmental and medical concerns. Care is supportive and tailored to the individual's needs.
6 comparison axes
Onset
22q Partial Monosomy C0265489
0-null
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
22q Partial Monosomy C0265489
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
22q Partial Monosomy C0265489
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
22q Partial Monosomy C0265489
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
22q Partial Monosomy C0265489
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
22q Partial Monosomy C0265489
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
22q-partial-monosomy-C0265489 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 22q Partial Monosomy C0265489 | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Genomic location | Missing material on chromosome 22; sometimes discussed within the DiGeorge or 22q11.2 spectrum. | A small missing segment at chromosome 13q12.3. | High |
| Recognized clinical pattern | Heart, immune, calcium, palate, and developmental features may occur, but vary widely. | Developmental and medical concerns are possible; a consistent pattern is not established here. | Moderate |
| Source severity label | Labeled severe in the supplied source. | Labeled moderate in the supplied source. | Low |
When to favor each condition
Choose 22q Partial Monosomy C0265489 when
Testing confirms partial monosomy or deletion involving chromosome 22.
The chromosomal location directly supports this diagnosis.
High
Compatible features prompt targeted 22q evaluation.
Clinical suspicion can guide testing, but confirmation is still required.
Moderate
Care planning involves cardiac, immune, endocrine, and developmental systems.
These areas are commonly considered, although involvement differs between people.
Moderate
Choose 13q12 3 Microdeletion Syndrome C4750951 when
Testing confirms a microdeletion at 13q12.3.
The specified chromosomal breakpoint region distinguishes it from 22q loss.
High
Developmental concerns occur with a 13q finding and no 22q abnormality.
The genetic result takes priority over overlapping nonspecific features.
Moderate
Counseling concerns a variable, sparsely characterized phenotype.
Management should be individualized because definitive features are not established here.
Moderate
How key tests differ
| Test | 22q Partial Monosomy C0265489 | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or cytogenetic analysis | Copy-number loss involving chromosome 22. | Microdeletion involving 13q12.3. | Genomic location distinguishes the conditions; results require clinical correlation. |
| Targeted 22q11.2 testing | May detect some, but not necessarily all, chromosome 22 losses. | Not expected to identify a 13q12.3 microdeletion. | A negative targeted test does not exclude another chromosomal diagnosis. |
| Organ-system assessment | Cardiac, immune, calcium, and developmental evaluations are often relevant. | No specific abnormality pattern is established by the supplied data. | Abnormal results are findings, not diagnoses by themselves. |
Prognosis comparison
22q Partial Monosomy C0265489
- Outcome
- Often chronic and potentially complex, but individual outcomes vary widely.
- Factors
- Deletion extent, involved organs, complications, and access to coordinated care.
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- Long-term outcome is not established from the supplied sparse data.
- Factors
- Deletion size, involved genes, associated findings, and individual support needs.
Time frame: Both are congenital and may have chronic effects; no reliable timeline is established here.
Avoid general mortality or severity predictions; clinician interpretation is essential.
Complications comparison
| Complication | Presentation |
|---|---|
| Congenital cardiac involvement | May occur and can substantially affect care. Not established as characteristic from the supplied data. Any suspected heart finding needs clinician-directed evaluation. |
| Immune or calcium disturbance | May be relevant in some people with 22q-related conditions. No specific association is established here. Laboratory abnormalities require interpretation and are not automatic diagnoses. |
| Developmental needs | Developmental, learning, or behavioral needs may occur. Developmental concerns are possible but variable. Support should follow individual assessment rather than the syndrome label alone. |
Patient education highlights
- HighGenetic confirmation
The diagnosis depends on the chromosomal result and clinical interpretation, not symptoms alone.
- HighSpecialized follow-up
Care is usually multidisciplinary and lifelong or long-term, tailored to affected organs and development.
- MediumFamily implications
Inheritance and recurrence risk vary; a genetics professional should provide counseling.